Solvay transfers innovative PRIEX® technology to Addcomp
Embargo : July 3, 2008 at 12:00 AM (Brussels Time)
A complete range of additives to boost the performance of polyolefin plastics
Solvay announces today that it has completed the transfer of its Priex® technology to Addcomp Holland BV, the Netherlands-based plastics additives manufacturer. Priex® is a range of functionalized homopolymers and copolymers capable of substantially enhancing mechanical, thermal and processing properties of polyolefin plastic resins. These innovative products were successfully developed by Solvay’s New Business Development (NBD) team at the Group’s Research & Technology campus in Neder-over-Heembeek, Belgium.
The financial details of the transfer, which covers technology, production equipment and know-how, will not be disclosed.
The integration of Priex® additives into existing grades of polyolefin resins makes these cost-effective products fit for use in more demanding applications, such as protective coating for beverage cans, multi-material assembling or manufacturing of plastic composites reinforced with natural fibres.
The strategic fit of Priex® with Solvay’s activities in the Plastics Sector has become limited because, among other reasons, the Group completed the divestiture of its polyolefin production in 2005.
“Priex® illustrates the dynamism of innovation within Solvay,” commented Leopold Demiddeleer, Corporate R&D and New Business Development Director, Solvay. “We believe that Addcomp is in the best position to realize the full potential of this technology as a range of innovative solutions specifically designed for polyolefin manufacturers,” Leopold Demiddeleer added.
ADDCOMP HOLLAND BV develops and produces one-pack additive systems for application in Polyolefins, Polystyrene (PS), Polyester (PET), Polyamides (PA), etc. The company focused on providing innovations to customers and therefore invests significant resources in product- and process development. Additive systems enhance the performance of polymers.
SOLVAY is an international chemical and pharmaceutical Group with headquarters in Brussels. It employs more than 28,000 people in 50 countries. In 2007, its consolidated sales amounted to EUR 9.6 billion, generated by its three sectors of activity: Chemicals, Plastics and Pharmaceuticals. Solvay is listed on the NYSE Euronext stock exchange in Brussels (NYSE Euronext: SOLB.BE - Bloomberg: SOLB.BB - Reuters: SOLBt.BR). Details are available at www.solvay.com
